938 related articles for article (PubMed ID: 19386548)
21. Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.
Komaki R; Shin DM; Glisson BS; Fossella FV; Murphy WK; Garden AS; Oswald MJ; Hong WK; Roth JA; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):807-11. PubMed ID: 7860392
[TBL] [Abstract][Full Text] [Related]
22. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
23. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
Kamath SS; McCarley DL; Zlotecki RA
Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
[TBL] [Abstract][Full Text] [Related]
24. Twice-daily prophylactic cranial irradiation for patients with limited disease small-cell lung cancer with complete response to chemotherapy and consolidative radiotherapy: report of a single institutional phase II trial.
Wolfson AH; Bains Y; Lu J; Etuk B; Sridhar K; Raub W; Markoe A
Am J Clin Oncol; 2001 Jun; 24(3):290-5. PubMed ID: 11404503
[TBL] [Abstract][Full Text] [Related]
25. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.
Aluwini S; Pos F; Schimmel E; van Lin E; Krol S; van der Toorn PP; de Jager H; Dirkx M; Alemayehu WG; Heijmen B; Incrocci L
Lancet Oncol; 2015 Mar; 16(3):274-83. PubMed ID: 25656287
[TBL] [Abstract][Full Text] [Related]
26. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.
Aluwini S; Pos F; Schimmel E; Krol S; van der Toorn PP; de Jager H; Alemayehu WG; Heemsbergen W; Heijmen B; Incrocci L
Lancet Oncol; 2016 Apr; 17(4):464-474. PubMed ID: 26968359
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic cranial irradiation for patients with limited-stage small-cell lung cancer with response to chemoradiation.
Tai P; Assouline A; Joseph K; Stitt L; Yu E
Clin Lung Cancer; 2013 Jan; 14(1):40-4. PubMed ID: 22673624
[TBL] [Abstract][Full Text] [Related]
28. Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937.
Gore EM; Hu C; Sun AY; Grimm DF; Ramalingam SS; Dunlap NE; Higgins KA; Werner-Wasik M; Allen AM; Iyengar P; Videtic GMM; Hales RK; McGarry RC; Urbanic JJ; Pu AT; Johnstone CA; Stieber VW; Paulus R; Bradley JD
J Thorac Oncol; 2017 Oct; 12(10):1561-1570. PubMed ID: 28648948
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic cranial irradiation in limited disease small-cell lung cancer in complete remission: a retrospective analysis.
van der Linden YM; van Kempen ML; van der Tweel I; Vanderschueren RG; Schlösser NJ; Lammers JW; Struikmans H
Respir Med; 2001 Mar; 95(3):235-6. PubMed ID: 11266242
[TBL] [Abstract][Full Text] [Related]
30. Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients.
Arriagada R; Le Chevalier T; Rivière A; Chomy P; Monnet I; Bardet E; Santos-Miranda JA; Le Péhoux C; Tarayre M; Benhamou S; Laplanche A
Ann Oncol; 2002 May; 13(5):748-54. PubMed ID: 12075744
[TBL] [Abstract][Full Text] [Related]
31. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
Thatcher N; Hirsch FR; Luft AV; Szczesna A; Ciuleanu TE; Dediu M; Ramlau R; Galiulin RK; Bálint B; Losonczy G; Kazarnowicz A; Park K; Schumann C; Reck M; Depenbrock H; Nanda S; Kruljac-Letunic A; Kurek R; Paz-Ares L; Socinski MA;
Lancet Oncol; 2015 Jul; 16(7):763-74. PubMed ID: 26045340
[TBL] [Abstract][Full Text] [Related]
32. [Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases].
Yue X; Zang QC
Ai Zheng; 2004 Dec; 23(12):1671-6. PubMed ID: 15601558
[TBL] [Abstract][Full Text] [Related]
33. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects.
Stuschke M; Eberhardt W; Pöttgen C; Stamatis G; Wilke H; Stüben G; Stöblen F; Wilhelm HH; Menker H; Teschler H; Müller RD; Budach V; Seeber S; Sack H
J Clin Oncol; 1999 Sep; 17(9):2700-9. PubMed ID: 10561344
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases.
Shaw EG; Su JQ; Eagan RT; Jett JR; Maksymiuk AW; Deigert FA
J Clin Oncol; 1994 Nov; 12(11):2327-32. PubMed ID: 7964948
[TBL] [Abstract][Full Text] [Related]
35. Factors affecting the risk of brain metastasis in small cell lung cancer with surgery: is prophylactic cranial irradiation necessary for stage I-III disease?
Gong L; Wang QI; Zhao L; Yuan Z; Li R; Wang P
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):196-200. PubMed ID: 22818415
[TBL] [Abstract][Full Text] [Related]
36. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
37. Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.
Li N; Zeng ZF; Wang SY; Ou W; Ye X; Li J; He XH; Zhang BB; Yang H; Sun HB; Fang Q; Wang BX
Ann Oncol; 2015 Mar; 26(3):504-9. PubMed ID: 25515658
[TBL] [Abstract][Full Text] [Related]
38. Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission.
Prophylactic Cranial Irradiation Overview Collaborative Group
Cochrane Database Syst Rev; 2000; (4):CD002805. PubMed ID: 11034766
[TBL] [Abstract][Full Text] [Related]
39. Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial.
Paz-Ares L; de Marinis F; Dediu M; Thomas M; Pujol JL; Bidoli P; Molinier O; Sahoo TP; Laack E; Reck M; Corral J; Melemed S; John W; Chouaki N; Zimmermann AH; Visseren-Grul C; Gridelli C
Lancet Oncol; 2012 Mar; 13(3):247-55. PubMed ID: 22341744
[TBL] [Abstract][Full Text] [Related]
40. Impact of prophylactic cranial irradiation on pattern of brain metastases as a first recurrence site for limited-disease small-cell lung cancer.
Nakamura M; Onozawa M; Motegi A; Hojo H; Zenda S; Nakamura N; Udagawa H; Kirita K; Matsumoto S; Umemura S; Yoh K; Niho S; Goto K; Akimoto T
J Radiat Res; 2018 Nov; 59(6):767-773. PubMed ID: 30102326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
